Its its overexpression evades the stress signals triggered by the DNA damage response (DDR) pathways; thus, BC subtypes, as well as other HER2+ cancers such as breast cancer, have a significantly poorer prognosis and more aggressive behavior. Here, ERBB2 is linked to breast carcinoma.